These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37194050)

  • 1. Diffuse intrapulmonary mesothelioma mimicking pulmonary lepidic adenocarcinoma: a rare case report and review of the literature.
    RanYue W; ChunYan W; Likun H; LiPing Z; JieLu L; ZhengWei D
    Diagn Pathol; 2023 May; 18(1):64. PubMed ID: 37194050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudocarcinomatous Mesothelioma: A Hitherto Unreported Presentation closely simulating primary lung cancer.
    Rossi G; Caroli G; Caruso D; Stella F; Davoli F
    Int J Surg Pathol; 2021 Oct; 29(7):775-779. PubMed ID: 33624546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesothelioma: morphologic and immunohistochemical findings.
    Churg A
    Pathologie (Heidelb); 2024 Sep; 45(5):309-315. PubMed ID: 38568257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma.
    Attanoos RL; Galateau-Salle F; Gibbs AR; Muller S; Ghandour F; Dojcinov SD
    Histopathology; 2002 Jul; 41(1):42-9. PubMed ID: 12121236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse intrapulmonary malignant mesothelioma masquerading as interstitial lung disease: a distinctive variant of mesothelioma.
    Larsen BT; Klein JR; Hornychová H; Nuti R; Thirumala S; Leslie KO; Colby TV; Tazelaar HD
    Am J Surg Pathol; 2013 Oct; 37(10):1555-64. PubMed ID: 23797722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse intrapulmonary malignant mesothelioma presenting with miliary pulmonary nodules: A case report.
    Hida T; Hamasaki M; Matsumoto S; Abe S; Takakura K; Hiroshima K; Nabeshima K
    Pathol Int; 2015 Jun; 65(6):318-23. PubMed ID: 25759091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant Cytokeratin 20 Reactivity in Epithelioid Malignant Mesothelioma: A Case Report.
    Manur R; Lamzabi I
    Appl Immunohistochem Mol Morphol; 2019; 27(10):e93-e96. PubMed ID: 28248731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FISH analysis of intrapulmonary malignant mesothelioma without a clinically detectable primary pleural lesion: an autopsy case.
    Hasegawa M; Sakai F; Sato A; Tsubomizu S; Arimura K; Katsura H; Koh E; Sekine Y; Wu D; Hiroshima K
    Jpn J Clin Oncol; 2014 Dec; 44(12):1239-42. PubMed ID: 25425731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lepidic intrapulmonary growth of malignant mesothelioma presenting as recurrent hydropneumothorax.
    Wu H; Tino G; Gannon FH; Kaiser LR; Pietra GG
    Hum Pathol; 1996 Sep; 27(9):989-92. PubMed ID: 8816899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma.
    Mansour MSI; Huseinzade A; Seidal T; Hejny K; Maty A; Taheri-Eilagh F; Mager U; Dejmek A; Dobra K; Brunnström H
    Cytopathology; 2023 Sep; 34(5):456-465. PubMed ID: 37337638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcomatoid mesothelioma diagnosed in a patient with mesothelioma in situ: a case report on morphologic differences after 9-month interval with details analysis of cytology in early-stage mesothelioma.
    Yoshida M; Jimbo N; Tsukamoto R; Itoh T; Kawahara K; Mitsui S; Tanaka Y; Maniwa Y
    Diagn Pathol; 2023 Nov; 18(1):126. PubMed ID: 38017544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
    Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
    Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calretinin-expressing lung adenocarcinoma: Distinct characteristics of advanced stages, smoker-type features, and rare expression of other mesothelial markers are useful to differentiate epithelioid mesothelioma.
    Matsuda M; Ninomiya H; Wakejima R; Inamura K; Okumura S; Mun M; Kitagawa M; Ishikawa Y
    Pathol Res Pract; 2020 Mar; 216(3):152817. PubMed ID: 32008868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and limitation of MTAP immunohistochemistry in diagnosing desmoplastic mesothelioma/sarcomatoid pleural mesothelioma with desmoplastic features.
    Sa-Ngiamwibool P; Hamasaki M; Kinoshita Y; Matsumoto S; Sato A; Tsujimura T; Kasai T; Hiroshima K; Kushitani K; Takeshima Y; Kawahara K; Iwasaki A; Nabeshima K
    Ann Diagn Pathol; 2022 Oct; 60():152004. PubMed ID: 35797798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of immunohistochemistry markers for malignant pleural mesothelioma diagnosis and subtypes. A systematic review and meta-analysis.
    Parra-Medina R; Castañeda-González JP; Chaves-Cabezas V; Alzate JP; Chaves JJ
    Pathol Res Pract; 2024 May; 257():155276. PubMed ID: 38603842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of prognostic histological parameters proposed for pleural mesothelioma in diffuse malignant peritoneal mesothelioma. A short report.
    Pezzuto F; Vimercati L; Fortarezza F; Marzullo A; Pennella A; Cavone D; Punzi A; Caporusso C; d'Amati A; Lettini T; Serio G
    Diagn Pathol; 2021 Jul; 16(1):64. PubMed ID: 34294087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma.
    Kinoshita Y; Hida T; Hamasaki M; Matsumoto S; Sato A; Tsujimura T; Kawahara K; Hiroshima K; Oda Y; Nabeshima K
    Cancer Cytopathol; 2018 Jan; 126(1):54-63. PubMed ID: 29053210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual intraparenchymal growth patterns of malignant pleural mesothelioma.
    Nind NR; Attanoos RL; Gibbs AR
    Histopathology; 2003 Feb; 42(2):150-5. PubMed ID: 12558747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highlighting the immunohistochemical differences of malignant mesothelioma subtypes via case presentations.
    Sejben A; Pancsa T; Tiszlavicz L; Furák J; Paróczai D; Zombori T
    Thorac Cancer; 2023 Apr; 14(10):857-863. PubMed ID: 36808895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma.
    Klebe S; Swalling A; Jonavicius L; Henderson DW
    J Clin Pathol; 2016 Feb; 69(2):136-41. PubMed ID: 26281863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.